Cunninghamella as a Microbiological Model for Metabolism of Histamine H3 Receptor Antagonist 1-[3-(4-tert-Butylphenoxy)propyl]piperidine

被引:0
|
作者
Elżbieta Pękala
Paulina Kubowicz
Dorota Łażewska
机构
[1] Jagiellonian University Medical College,Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy
来源
关键词
Cunninghamella; Biotransformation; Microbiological model; In vitro metabolism; In silico metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the study was to analyze the ability of the microorganism Cunninghamella to carry out the biotransformation of 1-[3-(4-tert-butylphenoxy)propyl]piperidine (DL76) and to compare the obtained results with in silico models. Biotransformation was carried out by three strains of filamentous fungus: Cunninghamella echinulata, Cunninghamella blakesleeana, and Cunninghamella elegans. Most probable direction of DL76 metabolic transition was the oxidation of the methyl group in the tert-butyl moiety leading to the formation of the metabolite with I° alcohol properties. This kind of reaction was conducted by all three strains tested. However, only in the case of C. blakesleeana that biotransformation product had a structure of carboxylic acid. CYP2C19 was identified by Metasite software to be the isoform of major importance in the oxidation process in the tert-butyl moiety of DL76. In silico data coincide with the results of experiments conducted in vitro. It was confirmed that Cunninghamella fungi are a very good model to study the metabolism of xenobiotics. The computational methods and microbial models of metabolism can be used as useful tools in early ADME-Tox assays in the process of developing new drug candidates.
引用
收藏
页码:1584 / 1593
页数:9
相关论文
共 50 条
  • [1] Cunninghamella as a Microbiological Model for Metabolism of Histamine H3 Receptor Antagonist 1-[3-(4-tert-Butylphenoxy)propyl]piperidine
    Pekala, Elzbieta
    Kubowicz, Paulina
    Lazewska, Dorota
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2012, 168 (06) : 1584 - 1593
  • [2] DETERMINATION OF IN VITRO METABOLISM OF A NEW NON-IMIDAZOLE HISTAMINE H3 RECEPTOR ANTAGONIST 1-[3-(4-TERT-BUTYLPHENOXY)PROPYL]PIPERIDINE
    Kryczyk-Poprawa, Agata
    Szafarz, Malgorzata
    Palak, Aneta
    Lazewska, Dorota
    Kus, Kamil
    Opoka, Wlodzimierz
    Szymura-Oleksiak, Joanna
    ACTA POLONIAE PHARMACEUTICA, 2019, 76 (05): : 877 - 884
  • [3] Pharmacokinetics and tissue distribution of the new non-imidazole histamine H3 receptor antagonist 1-[3-(4-tert-butylphenoxy)propyl]piperidine in rats
    Szafarz, Malgorzata
    Kryczyk, Agata
    Lazewska, Dorota
    Kiec-Kononowicz, Katarzyna
    Wyska, Elzbieta
    XENOBIOTICA, 2015, 45 (10) : 912 - 920
  • [4] LC–MS–MS Method for the Analysis of New Non-Imidazole Histamine H3 Receptor Antagonist 1-[3-(4-tert-Butylphenoxy)propyl]piperidine in Rat Serum—Application to Pharmacokinetic Studies
    Malgorzata Szafarz
    Joanna Szymura-Oleksiak
    Dorota Lazewska
    Katarzyna Kiec-Kononowicz
    Chromatographia, 2011, 73 : 913 - 919
  • [5] LC-MS-MS Method for the Analysis of New Non-Imidazole Histamine H3 Receptor Antagonist 1-[3-(4-tert-Butylphenoxy)propyl]piperidine in Rat Serum-Application to Pharmacokinetic Studies
    Szafarz, Malgorzata
    Szymura-Oleksiak, Joanna
    Lazewska, Dorota
    Kiec-Kononowicz, Katarzyna
    CHROMATOGRAPHIA, 2011, 73 (9-10) : 913 - 919
  • [6] Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors
    Lazewska, Dorota
    Olejarz-Maciej, Agnieszka
    Reiner, David
    Kaleta, Maria
    Latacz, Gniewomir
    Zygmunt, Malgorzata
    Doroz-Plonka, Agata
    Karcz, Tadeusz
    Frank, Annika
    Stark, Holger
    Kiec-Kononowicz, Katarzyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [7] BF2.649 [1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor:: Preclinical pharmacology
    Ligneau, X.
    Perrin, D.
    Landais, L.
    Camelin, J. -C.
    Calmels, T. P. G.
    Berrebi-Bertrand, I.
    Lecomte, J. -M.
    Parmentier, R.
    Anaclet, C.
    Lin, J. -S.
    Bertaina-Anglade, V.
    la Rochelle, C. Drieu
    d'Aniello, F.
    Rouleau, A.
    Gbahou, F.
    Arrang, J. -M.
    Ganellin, C. R.
    Stark, H.
    Schunack, W.
    Schwartz, J. -C.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (01): : 365 - 375
  • [8] BINDING OF 1-[3-(4-TERT-BUTYL-PHENOXY)PROPYL]PERIDINE, A NEW NON IMIDAZOLE HISTAMINE H3 RECEPTOR ANTAGONIST TO BOVINE SERUM ALBUMIN
    Szymura-Oleksiak, Joanna
    Kryczyk, Agata
    Szafarz, Malgorzata
    Jawien, Wojciech
    Lazewska, Dorota
    Kiec-Kononowicz, Katarzyna
    ACTA POLONIAE PHARMACEUTICA, 2012, 69 (06): : 1043 - 1047
  • [9] Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates
    Lazewska, Dorota
    Wiecek, Malgorzata
    Ligneau, Xavier
    Kottke, Tim
    Weizel, Lilia
    Seifert, Roland
    Schunack, Walter
    Stark, Holger
    Kiec-Kononowicz, Katarzyna
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (23) : 6682 - 6685
  • [10] INFLUENCE OF THE LIPOPHILIC PART OF 3-(1H-IMIDAZOL-4-YL)PROPYL CARBAMATES ON HISTAMINE H3/H4 RECEPTOR AFFINITY, SELECTIVITY, AND POTENCY
    Wiecek, M.
    Kottke, T.
    Seifert, R.
    Stark, H.
    Kiec-Kononowicz, K.
    INFLAMMATION RESEARCH, 2012, 61 : S75 - S75